What is the management of seizures in a pediatric patient weighing 9 kilograms using Midazolam (Versed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 9 kg pediatric patient experiencing seizures, the recommended dose of midazolam (Versed) is 0.2 mg/kg, which translates to 1.8 mg per dose for this child, as per the most recent and highest quality study available 1.

Key Considerations

  • Midazolam can be administered intramuscularly (IM) for seizures, with a maximum dose of 6 mg per dose, and may be repeated every 10–15 min if necessary.
  • It is crucial to be prepared to provide respiratory support, as there is an increased incidence of apnea when midazolam is combined with other sedative agents.
  • Monitoring oxygen saturation is essential, and flumazenil may be administered to reverse life-threatening respiratory depression caused by benzodiazepines such as midazolam, although it will also reverse the anticonvulsant effects and may precipitate seizures.

Administration and Monitoring

  • For IV administration, midazolam should be given slowly over 2-3 minutes to avoid respiratory depression.
  • The dose may be repeated once after 5-10 minutes if seizures persist, but it is essential to be vigilant for respiratory depression, especially after multiple doses or when combined with other sedatives.
  • Always have resuscitation equipment ready, monitor vital signs closely, and be prepared to provide respiratory support if needed.

Mechanism of Action

  • Midazolam works by enhancing the effect of the inhibitory neurotransmitter GABA in the brain, which increases chloride conductance through GABA-regulated channels, resulting in membrane hyperpolarization and seizure suppression.

Further Evaluation

  • After acute management, further evaluation for the underlying cause of seizures is essential, as per the guidelines for pediatric emergencies 1.

From the FDA Drug Label

The safety and efficacy of midazolam for sedation/anxiolysis/amnesia following single dose intramuscular administration, intravenously by intermittent injections and continuous infusion have been established in pediatric and neonatal patients UNLIKE ADULT PATIENTS, PEDIATRIC PATIENTS GENERALLY RECEIVE INCREMENTS OF MIDAZOLAM ON A MG/KG BASIS. Younger (less than six years) pediatric patients may require higher dosages (mg/kg) than older pediatric patients, and may require closer monitoring.

For a pediatric patient weighing 9 kg with seizures, the dosage of midazolam should be calculated based on the patient's weight.

  • The dosage for pediatric patients is generally higher than for adults on a mg/kg basis.
  • Younger pediatric patients (less than 6 years) may require higher dosages and closer monitoring.
  • The exact dosage cannot be determined without more specific information about the patient's condition and the desired level of sedation. 2

From the Research

Seizure Management in Pediatrics

  • The management of seizures in pediatric patients, including those weighing 9 kg, involves the use of anticonvulsant medications such as benzodiazepines 3, 4, 5.
  • Benzodiazepines, including midazolam, diazepam, and lorazepam, are considered first-line treatments for acute tonic-clonic convulsions and convulsive status epilepticus in children 3, 4, 5.

Midazolam Dosage and Administration

  • The dosage of midazolam for pediatric patients can vary depending on the route of administration and the patient's weight 6.
  • Intramuscular midazolam dosages can range from 0.1 to 0.2 mg/kg, while intranasal midazolam dosages can range from 0.1 to 0.2 mg/kg 6.
  • Buccal midazolam has been shown to be effective in controlling seizures in pediatric patients, with a dosage of 0.5 mg/kg 3.

Comparison of Anticonvulsant Medications

  • Intravenous lorazepam has been shown to be as effective as intravenous diazepam in the treatment of acute tonic-clonic convulsions, with fewer adverse events 3, 5.
  • Buccal midazolam has been shown to be more effective than rectal diazepam in controlling seizures in pediatric patients 3, 5.
  • Intranasal midazolam has been shown to be as effective as intravenous diazepam in the treatment of prolonged febrile convulsions 5.

Safety and Efficacy

  • The safety and efficacy of midazolam in pediatric patients have been established, with no major side effects reported in one study 7.
  • The use of benzodiazepines, including midazolam, has been associated with a low risk of adverse events, including respiratory depression 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Role of Benzodiazepines in the Treatment of Epilepsy.

Current treatment options in neurology, 2016

Research

Midazolam as a first-line treatment for neonatal seizures: Retrospective study.

Pediatrics international : official journal of the Japan Pediatric Society, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.